NADER SHAKIR: Open Payments
NPI 1750811535 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 11 payments from 7 companies in 2025. Trend: 2023 $78 · 2024 $189 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Tris Pharma Inc | 1 | $21 |
Products named: VIVITROL, UZEDY, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, COBENFY, INVEGA SUSTENNA, Onyda XR.
Industry payments across CA — which companies pay providers there.
